(Total Views: 229)
Posted On: 03/13/2018 4:09:59 PM
Post# of 72443
Do you have an industry comp for that? PCYC was acquired for Imbruvica in 2015 for $21B. At the time Imbruvica was slated for $5B/year in 2020, approved in 50 countries and was in 13 phase 3 trials.
And this is coming for a guy who thinks we will be bought out for $8-30/share ($1B-4B), not some ihub hater. I just don't see any data that supports $15B-30B as a reasonable buyout number.
Go IPIX!
And this is coming for a guy who thinks we will be bought out for $8-30/share ($1B-4B), not some ihub hater. I just don't see any data that supports $15B-30B as a reasonable buyout number.
Go IPIX!
(0)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼
